Anti-inflammatory therapies in COPD, e.g. inhaled corticosteroids, have not been consistently shown to modify serum levels of CRP or IL-6, nor the long-term cardiovascular complications [9], [10]. This evidence concerns the gene IL6 and chronic obstructive pulmonary disease.